UVAX BIO
Uvax Bio is a biotechnology company developing vaccines using patented protein nanoparticle technology.
UVAX BIO
Social Links:
Industry:
Biopharma Biotechnology
Founded:
2018-01-01
Address:
Newark, Delaware, United States
Country:
United States
Website Url:
http://www.uvaxbio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
20 M USD
Technology used in webpage:
Euro Amazon
Similar Organizations
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
EpiVario
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Pleno
Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2023-09-13 | Uvax Bio Appoints Pedro Garbes, MD., as Vice President, Global Medical Lead |
Official Site Inspections
http://www.uvaxbio.com
- Host name: ec2-52-22-145-238.compute-1.amazonaws.com
- IP address: 52.22.145.238
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Uvax Bio"
About | Antibody-Based Biotech Vaccines - Uvax Bio
Uvax bio is a spinoff company from Scripps Research, using a safe and effective vaccine pipeline to create antibody-based vaccines to improve human health. See details»
Uvax Bio - LinkedIn
Uvax Bio | 2,090 followers on LinkedIn. Addressing global health challenges through innovative vaccines | Founded in early 2018, Uvax Bio, a spin-off vaccine company from Scripps Research, … See details»
Uvax Bio - Crunchbase Company Profile & Funding
Uvax Bio is a biotechnology company developing vaccines using patented protein nanoparticle technology. See details»
Uvax Bio - The Org
Founded in early 2018, Uvax Bio, a spin-off vaccine company from Scripps Research, La Jolla, CA, employs patented single-component self-assembling protein nanoparticle (1c-SApNP) platform … See details»
Uvax Bio - Craft
Uvax Bio is a spin-off vaccine company that employs patented single-component self-assembling protein nanoparticle platform technology. It develops and commercializes B-cell focused, rapid … See details»
Uvax Bio, LLC | Life Sciences PA
About. Founded in early 2018, Uvax Bio, a spin-off vaccine company from Scripps Research, employs patented single-component self-assembling protein nanoparticle (1c-SApNP) platform … See details»
Uvax Bio 2025 Company Profile: Valuation, Funding & Investors
Uvax Bio General Information Description. Operator of a biotechnology company intended to create nanoparticle vaccine through antigen design. The company's platform develops and … See details»
Uvaxbio - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Study to assess safety and immunogenicity of novel protein nanoparticle vaccine candidates UVAX-1107 and UVAX-1197 in healthy volunteers NEWARK, Del.--(BUSINESS … See details»
Uvax Bio Announces Dosing of First Participant in Phase 1 Clinical ...
NEWARK, Del., January 30, 2024--Uvax Bio, LLC, ("Uvax" or "the Company") a privately held, clinical-stage vaccine company utilizing rational and computational biology to design and deliver … See details»
Uvax Bio Receives Approval to Initiate a Phase 1 Clinical Trial of ...
Dec 19, 2023 Kevin O’Neill SVP, Corporate Strategy [email protected] 302-595-2285 Release Summary Uvax Bio receives approval to start a Phase 1 clinical study for its novel HIV-1 protein … See details»
UVAX BIO, LLC Company Profile | Newark, DE - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for UVAX BIO, LLC of Newark, DE. Get the latest business insights from Dun & Bradstreet. See details»
Uvax Bio | Home | BioTech Pharmaceutical Company Vaccines
Uvax Bio has a safe and effective vaccine pipeline for the future, supporting health and improving human life through breakthrough proprietary technology. See details»
Uvax Bio | Pipeline | Vaccine Biotech Pharmaceutical
Learn about the antibody-eliciting vaccines currently in development. Uvax Bio challenges diseases with preventative vaccines to improve global health. See details»
Uvax Bio Announces Interim Results from a Phase 1 Clinical Trial ...
Nov 19, 2024 According to the World Health Organization (WHO), an estimated 1.3 million people worldwide become infected with HIV annually. Globally, 9.2 million people living with HIV are not … See details»
Uvax Bio Announces Publication of Results from Preclinical
Apr 26, 2023 Uvax Bio-owned vaccines demonstrated significant improvement in immune response compared with current vaccine strategies; Phase 1 clinical trial sponsored by National Institutes of … See details»
Uvax Bio | Contact | Biotech Pharmaceutical Vaccines
Contact Uvax Bio in Delaware to learn more about how we're transforming the world with a streamlined vaccine development pipeline using proprietary technology. See details»
Uvax Bio | Our Technology | Biotech Pharmaceutical Company
Our vision is to become a global leader in the vaccine industry using proprietary technology and a streamlined pipeline to confront challenging global diseases. See details»
Uvax Bio Announces Publication of Results from Preclinical Studies of ...
Apr 26, 2023 Uvax Bio-owned vaccines demonstrated significant improvement in immune response compared with current vaccine strategiesPhase 1 clinical trial sponsored by National Institutes of … See details»
Partners | Investors |Proprietary Vaccine Biotech - Uvax Bio
Join our current partners and investors who are helping us to change the world with accelerated vaccine development and a streamlined production pipeline. See details»
News and Publications | Biotech + Vaccine News - Uvax Bio
Read Uvax Bio in the news for vaccine development and the implementation of proprietary technology to streamline the pipeline of preventative medicine. See details»